Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
BioMarket Trends: Diagnostic Tools Change Cancer Treatment
Assessing Disease Predisposition, Progression, Recurrence, and Therapeutic Response
- One of the greatest challenges facing clinicians in treating cancer is early diagnosis when there is sufficient time to utilize multiple treatment algorithms. Current diagnostic tools, which include various blood marker-based immuonoassays, imaging techniques, and biopsy analysis, provide valuable information but have inherent limitations in sensitivity and specificity, involve ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.